AI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patient… (NCT07684690) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
AI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patients Managed by Non-Specialist Physicians
Taiwan400 participantsStarted 2026-07
Plain-language summary
This study tests whether an artificial intelligence (AI) tool can help doctors choose better diabetes medicines for their patients. Type 2 diabetes is very common, but there are far more patients than diabetes specialists, so many patients are treated by doctors who are not diabetes specialists. The researchers built an AI consultation system that gives doctors real-time suggestions and predictions about diabetes medicines while they are prescribing. The doctor always makes the final decision.
In this trial, patients with type 2 diabetes whose blood sugar is not well controlled will be placed by chance (randomly) into one of two groups. In one group, the doctor uses the AI system when deciding on diabetes medicines. In the other group, the doctor prescribes as usual, without the AI system. All medicines used are already approved in Taiwan and given at approved doses.
The study follows each patient for 12 months, with check-ups at the start and at 3, 6, 9, and 12 months. The main goal is to compare how much the patients' long-term blood sugar level (HbA1c) improves between the two groups after one year. The researchers also look at how many patients reach their blood sugar target, how often low blood sugar happens, and whether any side effects occur. The aim is to find out whether using the AI tool leads to better blood sugar control.
Who can participate
Age range
19 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 to 80 years
* Diagnosis of type 2 diabetes for at least 6 months
* HbA1c above 8% within the past 3 months
* Currently using one or more oral antidiabetic drugs
* Able to understand and provide written informed consent
Exclusion Criteria:
* Pregnancy or breastfeeding
* Recent participation in another interventional clinical trial
* Cognitive impairment precluding understanding of the study
* Active cancer treatment within the past 6 years
* Use of systemic steroids
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial uses an AI system to help non-specialist doctors make antidiabetic drug decisions — can you explain how that AI would actually influence the medications I'd be prescribed, and how comfortable you are with that kind of decision-support tool?
2The trial hasn't started recruiting yet, so there's no safety or outcome data available at all — given that, would it make more sense for me to focus on established treatment options first while we wait to see how this study unfolds?
3The main thing this trial is measuring is HbA1c change over 12 months — if my HbA1c is already being managed reasonably well, is there still a meaningful reason for me to consider joining once it opens?
4Since this trial is specifically designed for patients managed by non-specialist physicians, does that mean my care during the study would be handled by a general practitioner rather than an endocrinologist, and how would that affect my overall diabetes management?
5Because this trial is listed as 'Phase NA,' which often applies to system or process studies rather than drug trials, can you help me understand what exactly is being tested here — the AI tool itself, or the medications it recommends — so I know what I'd actually be agreeing to?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.